Dr Reddy’s Shifts Drug Discovery Focus Away From Heart Disease

Drug firm Dr Reddy’s Laboratories said Monday it has shifted focus of its drug discovery to new segments, including dermatology and pain management, from cardiac diseases and diabetes due to high costs involved for the latter.
The Economic Times